ATTR program on hold amid safety risks; HAE therapy faces tough rivals and small market. Read more analysis here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results